Signal
Swiss Healthtech Hilo Secures $19 Million to Scale Cuffless Blood Pressure Monitoring
Summary
Aktiia's Hilo brand has extended its Series B to $119 million total, backed by the Dell Family Office. This capital injection accelerates the commercialization of wrist-worn optical sensor technology designed to replace the standard inflatable cuff for continuous hypertension management.
The company sits inside the Cardiovascular and Devices lane of the women's health map at Series B ($19M). Track it against comparable rounds to see whether pricing in this lane is holding.
OVUM interpretation layer
The editorial read on this signal — pattern, market-structure implications, and what to watch next.
Sources
- OVUM Primary source